In October, Stryker announced that it was estimating that the cost of litigation for the ABG II and Rejuvenate hip implants will range from $700 million to as much as $1.1 billion, according to an Oct. 23 Wall Street Journal report, "Stryker Says Hip Recall May Cost Up to $1.13 Billion."**
Dov Slansky, an attorney with the Rottenstein Law Group LLP, told CBS Radio on Nov. 13 that the purported DePuy settlement was “encouraging.”
“It’ll give those who have been injured some measure of justice,” he said.
There is no word yet on Stryker settlement talks, but the amount of money the company has set aside shows promise, said Rochelle Rottenstein, RLG’s principal.
“The company clearly is preparing to resolve these lawsuits, whether in court or through settlement offers,” she said. “There is a lot of data that show the alleged dangers of metal-on-metal hips—and certainly the mass settlement by another manufacturer over a similar product could serve to put pressure on Stryker to do the same.”
There are Stryker lawsuits consolidated for pretrial efficiency in federal and state courts. In New Jersey, there are 600 lawsuits consolidated in New Jersey Superior Court before Judge Brian R. Martinotti, according to court documents (In re: Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation; MCL-296, Bergen County Superior Court, New Jersey).
At the federal level, there are about 350 lawsuits consolidated in Minnesota, according to court documents (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation; MDL-2441, U.S. District Court for the District of Minnesota). There have not been any trials yet, because federal litigation is still in its early stages.